AMWI is set to open very strong tomorrow and continue its ascent as everyone’s eyes are now turned to one of most promising picks we have ever featured. Ironic how Abuseoflaw.org almost destroyed this hot penny stock until some further digging reveled the truth as you will see below.
It has been a crazy ride for what has definitely become our hottest pick of the year. AMWI truly is a blessing for our members, rising yet again today. It is up collectively 950% which is ridiculously impressive.
Although AMWI took a dramatic nosedive following some faulty accusations last week, the great news is that it’s on the rise again and we believe it will crush its last peak. AMWI brushed off the set back like a bug, and is now continuing its rapid ascent once again. This is a great sign, and to some: a second chance.
AMWI is recovering like no other pick in history, and now is your chance to jump on board!
When we first started looking at AMWI, our few subscribers that did not jump on board regretted that decision quite a bit as they watched it skyrocket well over 700%. Before we knew it, it was trading at nearly $1.50.
AMWI is now at only 48 cents, which is an absolute bargain compared to what we witnessed just a few days ago. This is a fresh opportunity for those who were hesitant to jump on this money train the first time around.
Consider what we saw last week an indication of what AMWI is capable of. In our opinion it is very likely that AMWI is headed right back in those sky high directions with enough momentum to become our hottest pick ever!
If history does indeed repeat itself, AMWI is headed for some massive upside from current levels!
There are two reason why we strongly believe that AMWI will jump right back:
1) The last time AMWI was trading within the current range, it skyrocketed to nearly 1.50$ in a matter of days. We believe this very well might happen again and we want all our subscribers to be on board this time. Do not be one of the few who misses out once again. Think about the facts; don’t all signs seem to point upwards?
2) The trends AMWI is following seems to resemble the trends of LEXG enormously, and we all know how amazing LEXG did, skyrocketing all the way to $12. Will AMWI rise as high as LEXG or leave LEXG in it’s dust? Either way, as you can clearly see we have many reasons to believe it’s headed towards amazing heights.
Current chart of AMWI as it runs:
At times I pay attention to companies that make NASDAQ’s “largest short interest” list to see if there are opportunities. While there are numerous reasons as to why a stock will appear: deteriorating fundamentals, new competitors, increased risk, and cyclicality. Another reason that can also warrant increased short seller attention: lawsuits.
Arena Pharmaceuticals, Inc. (ARNA), a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. ARNA has some lofty valuations, as most biotechnology companies do in their growth phase, at 19x P/S, 20x EV/S, and 8x P/B.
However, ARNA has considerable short interest as of Nov. 15 at approximately 17% and a short ratio nearing 19, causing me to dig deeper and see if such a negative bias is warranted. Moreover, on Dec.9, ARNA surged to an intra-day 52-week high, being up near 40% at one point on strong volume, leading me to research and see if the company is experiencing a classic short squeeze.
Looking at the historical performance of ARNA below, we see there was a big surge in July 2010 followed by a big plunge in Sept. 2010. So, I looked at the accompanying news to see the particular reasons, and we see the July move was related to optimism regarding ARNA ‘s weight loss drug, Lorcaserin, and the accompanying plunge in Sept. 2010 regarding unfavorable news from the FDA on the drug.
However, the company looked to be further depressed by a lawsuit. While it is still ongoing, the plaintiff, George Sharp, a private investor and experienced in legal matters has stated in his complaint the following: “The defendants deliberately deceived him by issuing false and misleading press releases indicating that Arena’s weight loss drug, Lorcaserin, was effective, tolerable, and officious, in line with United States Food and Drug Administration guidelines and qualifications. He further alleges that while the Defendants were touting Lorcaserin, they deliberately withheld data from the public regarding the relationship of the drug to cancer in rats.” I’m not a legal expert, but I’ve seen many lawsuits like these come about when a company plunges. So I dug further to see if ARNA is still a viable company, or if it really does have an unscrupulous management team as this lawsuit claims.
What I find very interesting is that the same plaintiff filed numerous lawsuits prior to this one and has filed at least three since that time as you can see here, including one this past Thursday, Dec. 8, regarding some micro-caps named Amwest Imaging Inc. (AMWI) and Writers’ Group (WRIT). I have no idea about the merits of these companies and lawsuits as I’m focused on researching ARNA.
Upon further research, I found a website dedicated to exposing his actions at “Abuseoflaw.org”. It looks as though their goal is simply “to see George A. Sharp and his group’s illegal activity stopped and we will use whatever legal means at our disposal to see him prosecuted to the fullest extent of the law.” It goes on describing directly from people involved here his very questionable ethics and accompanying sources to back up their claims.
Moreover, Abuseoflaw.org goes on to say “whether he is bashing the company he is in pre-lawsuit negotiations with or spreading negative information about a company he has already obtained a judgment against, he uses the aliases to instill fear in investors’ confidence in hopes of a drop in share price, which in turn encourages the company to quickly settle.” This to me raises considerable doubt that the lawsuit concerning ARNA will have a material effect going forward.
In addition, this is an example I’ve come across as an investor that it’s wise to always perform due diligence. In my early years, I would have taken this lawsuit at face value and just stopped researching ARNA. However, after looking deeper, I feel rather safe to assume there is not much merit to the lawsuit. So looking at the stock, – it has actually formed a strong base at its current share price between $1.50-2 over the past 12 months. Moreover, it currently has some credible owners in Renaissance Technologies, Wellington Management, and BlackRock to name a few, while working hard on making the necessary adjustments in getting Lorcaserin approved. I’d put ARNA as a very speculative buy, as the valuations aren’t obviously pretty, but technically ARNA has formed a strong base, broke out to a new 52-week high on Dec. 9, and looks committed to doing what is necessary in being able to enter the very profitable weight-loss market.
There is no doubt in our minds that we are all hoping to see AMWI go up to the multi-dollar range before Christmas.
We will continue covering AMWI at least through the end of the year as it could get extremely exciting, and will keep our members posted on a daily basis!
AMWI is bouncing back very rapidly. Smart judgement could definitely pay off!
Would you like to receive the #1 rated penny stock newsletter?
If you answered yes, then receiving Aim High Profits’ Penny Stock Alerts will help guide you to some of the biggest and most profitable trading alerts and techniques that are proven to bring in the “big bucks”.
AND AS ALWAYS…………..
- Do your own research.
- Verify everything.
- Do not use market orders to enter a position, use limit orders.
- If a stock gaps open look for pullbacks to enter.
- If a stock breaks below our alert price GET OUT. Do not wait.
- Always use stop loss orders to protect yourself.
- Always take your profits whenever you can. Do Not Be Greedy.
- Do something to make someone else’s life better today.
Good luck in making the best penny stock picks. Have Fun!!